LNA Santé (LNA) Q4 2024 TU earnings summary

Executive summary

• Operating revenue reached €793.9m in 2024, reflecting strong business momentum across all lines.

• Q4 saw a boost from outpatient care and hospital-at-home services, with organic growth of 9.4% after adjustments.

• Strategic focus on new care models and regional expansion supported growth.

Financial highlights

• Full-year operating sales rose 10.3% year-over-year to €793.9m; adjusted organic growth was 6.7%.

• Q4 operating sales were €211.8m, up 11.8% organically from Q4 2023.

• Healthcare France segment grew 14.2% to €447.5m; Medico-Social France up 5.4% to €300.8m.

• International sales increased 5.3% to €38.9m, driven by Belgium and Poland.

• Real estate sales rebounded in Q4, with €6.2m, but annual sales fell 22.5% to €12.7m.

Outlook and guidance

• Projected 2025 operating sales growth of 6.0%, targeting nearly €845m.

• Continued focus on outpatient and homecare services, with high occupancy rates expected.

• Ongoing implementation of the "Growing Together 3" project, with updates at annual results.